Isolated Conjunctival Lymphaticovenous Malformation Presenting as Persistent Conjunctival Chemosis

Victor Brantl; Elisabeth Messmer; Andreas Ohlmann; Siegfried Priglinger; Anna Schuh

doi:10.1055/a-2200-5062

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd
DOI: 10.1055/a-2200-5062

Kasuistik

Isolated Conjunctival Lymphaticovenous Malformation Presenting as Persistent Conjunctival Chemosis

Eine persistierende konjunktivale Chemose erwies sich als isolierte konjunktivale lymphatisch-venöse Malformation

Authors

Victor Brantl

Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
Elisabeth Messmer

Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
Andreas Ohlmann

Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
Siegfried Priglinger

Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
Anna Schuh

Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany

Abstract

Full Text

References

References
1 Shields JA, Mashayekhi A, Kligman BE. et al. Vascular tumors of the conjunctiva in 140 cases. Ophthalmology 2011; 118: 1747-1753
2 Murray N, McCluskey P, Wakefield D. et al. Isolated bulbar conjunctival Kaposiʼs sarcoma. Aust N Z J Ophthalmol 1994; 22: 81-82
3 Rootman J, Hay E, Graeb D. et al. Orbital-adnexal lymphangiomas. A spectrum of hemodynamically isolated vascular hamartomas. Ophthalmology 1986; 93: 1558-1570
4 Nassiri N, Rootman J, Rootman DB. et al. Orbital lymphaticovenous malformations: Current and future treatments. Surv Ophthalmol 2015; 60: 383-405
5 Jones IS. Lymphangiomas of the ocular adnexa. An analysis of sixty-two cases. Am J Ophthalmol 1961; 51: 481-509
6 Jakobiec FA, Werdich XQ, Chodosh J. et al. An analysis of conjunctival and periocular venous malformations: clinicopathologic and immunohistochemical features with a comparison of racemose and cirsoid lesions. Surv Ophthalmol 2014; 59: 236-244
7 Behrendt S, Bernsmeier H, Randzio G. Fractionated beta-irradiation of a conjunctival lymphangioma. Ophthalmologica 1991; 203: 161-163
8 Bansal S, Das S. Intralesional bleomycin: A treatment modality for conjunctival lymphangioma. Oman J Ophthalmol 2020; 13: 43-45
9 Abdelaziz O, Hassan F, Elessawy K. et al. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children. Cardiovasc Intervent Radiol 2019; 42: 433-440
10 Wiegand S, Eivazi B, Barth PJ. et al. Pathogenesis of lymphangiomas. Virchows Arch 2008; 453: 1-8
11 Cohen jr. MM. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A 2006; 140: 2013-2038
12 Harris GJ. Orbital vascular malformations: a consensus statement on terminology and its clinical implications. Orbital Society. Am J Ophthalmol 1999; 127: 453-455
13 Wassef M, Blei F, Adams D. ISSVA Board and Scientific Committee. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136: e203-e214
14 Duke-Elder S. Diseases of the Outer Eye. In: Duke-Elder S. ed. System of Ophthalmology, Vol. 8, Part 1. St. Louis, Mo, USA: Mosby; 1965